PTPN11 and non-small cell lung carcinoma: Using genomic and protein information from a large cohort of NSCLC patients, our most important observation was the strong negative correlation (r = -0.157, p-value = 0.0028**) between the active, tyrosyl-phosphorylated form of SHP-2 and PD-L1 protein expression (Fig 1A).